Obesity Management

BOSTON — Behavioral modification with diet and exercise demonstrated similar weight-loss benefits vs. other pharmaceutical and surgical approaches to obesity management, but patients must remain adherent, a speaker reported.

At current prices, bariatric surgery was more cost-effective than GLP-1 receptor agonists for treatment of obesity, researchers reported at the American College of Surgeons Clinical Congress.

The NIH announced that it has invested $30 million over 2024 and 2025 to pilot a national primary care research network that will integrate clinical research into community-based primary care.

Patients who were prescribed phentermine after losing fewer than 20 pounds while on a GLP-1 receptor agonist were more likely to lose weight 1 year after GLP-1 discontinuation than those who were not prescribed phentermine, recent findings show.

NEW ORLEANS — Nearly all adults who lose less than 5% of their body weight with tirzepatide at 12 weeks were able to achieve at least a 5% weight loss by 72 weeks, according to a post-hoc analysis of the SURMOUNT-1 trial.

DENVER — Losing weight is good for patients’ wallets as well as their health, according to a presenter at the Obesity Medicine Association’s annual conference.

In this video, Katherine Saunders, MD, DABOM, discusses the need for clinicians who are "culturally competent" and provide evidence-based, comprehensive obesity treatment.

In this video, Katherine Saunders, MD, DABOM, emphasizes the need for obesity medicine physicians and primary care physicians to work together on a patient's treatment.

In this video, Katherine Saunders, MD, DABOM, describes the thorough evaluation of each obesity patient to create a treatment plan tailored to their specific needs.